Immunogenicity and safety of a single dose of adjuvanted RSVPreF3 vaccine in adults ≥60 years of age in China: results from a phase 3 immunobridging trial中国≥60岁成人接种佐剂RSVPreF3疫苗单剂量的免疫原性和安全性：一项3期免疫桥接试验的结果Frontiers in ImmunologyIF5.92026-09-030OA
Late Breaking Abstract - Seroprevalence of Bordetella pertussis in chronic obstructive pulmonary disease (COPD) patientsEUROPEAN RESPIRATORY JOURNALIF212020-10-283PRE
Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label studyHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52020-08-264OAAI
Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative studyECLINICALMEDICINEIF102020-06-0110OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向